Natik Piri, Ph.D.

Natik Piri, Ph.D.



Faculty Member

Professor in Residence
Department of Ophthalmology
Jules Stein Eye Institute
David Geffen School of Medicine
University of California, Los Angeles

 

UCLA Jules Stein Eye Institute
100 Stein Plaza, Room B146
Los Angeles, CA 90095

 

Research Interests

Dr. Piri’s research is aimed toward understanding the molecular mechanisms leading to retinal ganglion cells (RGC) death in glaucoma. It has been established that RGCs die by apoptosis in glaucoma, but the exact pathway from death stimulus to cell death is not understood. As an initial step in identifying potential factors responsible for RGC apoptosis, Dr. Piri’s laboratory is analyzing gene expression patterns that are altered in glaucomatous retinas using DNA microarrays and proteomic technologies, as well as conventional molecular biology, biochemistry and genetic methods. Another area of interest is the identification of new genes that are expressed exclusively or preferentially in RGCs. Currently, Dr. Piri is investigating the roles of several RGC-expressed novel genes in RGC differentiation and metabolism, and their possible involvement in glaucomatous or other optic neuropathies. Gene and protein expression studies may lead to a better understanding of the regulatory events involved in RGC apoptosis, and provide molecular targets for the development of new therapeutic agents with neuroprotective effects in order to prevent or delay the loss of ganglion cells in glaucoma.

Publications